Abstract
Background: The Pericarbon Freedom stentless valve has shown excellent hemodynamic results in
the midterm course. However, there is no information as to whether a continuous or
interrupted suture technique at the inflow site has an impact on postoperative hemodynamics.
Methods: 139 patients were enrolled in a non-randomized, prospective matched trial. An interrupted
suture line technique was used in 68 patients and a continuous suture line technique
was used in 71 at the inflow site. Isolated valve replacement was performed in 70.4
% of the continuous and 67.6 % of the interrupted suture group. Pre- and postoperative
hemodynamics and one-year follow-up were obtained by echocardiography and expressed
as mean and peak gradients and grade of regurgitation. Results: No significant difference between continuous and interrupted suture techniques were
noted with respect to mean (11.8 ± 6.3 vs. 12.5 ± 6.2 mm Hg, p = 0.251) and peak gradients (21.0 ± 9.6 vs. 22.0 ± 10.9 mm Hg, p = 0.292) as well as to the degree of regurgitation. Bypass and cross-clamping times
decreased by 22.4 and 20.6 minutes, respectively, with the use of the continuous suture
technique. One year follow-up showed a further, significant decrease of mean and peak
gradients. Conclusions: The Pericarbon Freedom™ stentless valve appears to offer excellent postoperative
performance. The suture line technique at the inflow site does not result in any hemodynamic
differences.
Key words
Aortic valve replacement - stentless biological valve - implantation technique - postoperative
hemodynamics
References
- 1
Jin X Y, Gibson D G, Yacoub M H, Pepper J R.
Perioperative assessment of aortic homograft, Toronto stentless valve, and stented
valve in the aortic position.
Ann Thorac Surg.
1995;
60
S395-S401
- 2
Konertz W.
Stentless aortic xenograft heart valves.
Asian Cardiovasc Thorac Ann.
2003;
11
1-2
- 3
Stacchino C, Bona G, Rinaldi S, Vallana F.
Design and performance characteristics of the Pericarbon stentless valve.
J Heart Valve Dis.
1995;
4
S102-S105
- 4
Jin X Y, Westaby S.
Pericardial and porcine stentless aortic valves: Are they hemodynamically different?.
Ann Thorac Surg.
2001;
71
S311-S314
- 5
Westaby S.
Implant technique for the Sorin stentless pericardial valve.
Operat Tech Thorac Cardiovasc Surg.
2001;
6
101-115
- 6
Calafiore A M, Teodori G, Mezzetti et A.
al. Intermittent antegrade warm blood cardioplegia.
Ann Thorac Surg.
1995;
59
398-402
- 7
Nashef S A, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R.
Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational
database of 19 030 patients.
Eur J Cardiothorac Surg.
1999;
15
816-823
- 8
Bach D S, David T E, Yacoub M. et al .
Hemodynamics and left ventricular mass regression following implantation of the Toronto
SPV stentless porcine valve.
Am J Cardiol.
1998;
82
1214-1219
- 9
Ennker J, Rosendahl U, Ennker I C, Bauer S, Florath I.
Risk in elderly patients after stentless versus stented aortic valve surgery.
Asian Cardiovasc Thorac Ann.
2003;
11
37-41
- 10
Westaby S, Horton M, Jin X Y. et al .
Survival advantage of stentless aortic bioprostheses.
Ann Thorac Surg.
2000;
70
785-790
- 11
Seguin J R, Grandmougin D, Folliguet T, Warembourg H, Laborde F, Chaptal P A.
Long-term results with the Sorin Pericarbon valve in the aortic position: a multicenter
study.
J Heart Valve Dis.
1998;
7
278-282
- 12
Folliguet T A, Dibie A, Czitrom D, Le Bret E, Laborde F.
Ten-years' clinical experience with the Sorin Pericarbon valve.
J Heart Valve Dis.
2000;
9
423-428
- 13
Bonacchi M, Giunti G, Prifti E. et al. .
Early postoperative outcome and hemodynamic performance of the Sorin Pericarbon stentless
aortic valve.
J Heart Valve Dis.
2002;
11
703-709
- 14
Jin X Y, Westaby S, Gibson D G, Pillai R, Taggart D P.
Left ventricular remodelling and improvement in Freestyle stentless valve haemodynamics.
Eur J Cardiothorac Surg.
1997;
12
63-69
- 15
Kirklin J K, Westaby S, Blackstone E H, Kirklin J W, Chenoweth D E, Pacifico A D.
Complement and the damaging effects of cardiopulmonary bypass.
J Thorac Cardiovasc Surg.
1983;
86
845-857
- 16 Kirklin J W, Barrat-Boyes B G. Cardiac Surgery. 2nd ed. New York, Edinburgh, London,
Melbourne, Tokyo; Churchill Livingstone 1993: 129-166
1 Presented at the Satellite Symposium “Benefits of Bioprostheses” at the 4th joint
meeting of the German, Austrian and Swiss Societies for Thoracic and Cardiovascular
Surgery, February 15 - 18, 2004 in Hamburg.
M.D., PhD Sven Beholz
Department of Cardiovascular Surgery
Charité - University Medicine Berlin
Luisenstraße 65
10117 Berlin
Germany
Phone: + 4930450522196
Fax: + 49 3 04 50 52 29 21
Email: sven.beholz@charite.de